PURE Bioscience, Inc.
corporate_fare Company Profile
PURE Bioscience, Inc. (OTC:PURE) is a publicly traded company in the Industrial Applications And Services sector. Wiseek monitors PURE SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- PURE Bioscience Q3 Net Loss Widens to $624K on $506K Revenue
- PURE Bioscience Reports Increased Q3 Loss, Raises $1M in Dilutive Private Placement, and Authorizes 92% More Shares
- PURE Bioscience Reports Q3 Results with Surging Current Debt and CEO Transition
- PURE Bioscience Secures $1.0M in Dilutive Private Placement at Discounted Price
- PURE Bioscience Secures $1.0M Private Placement, Directors Invest Heavily Amidst Going Concern Warning
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for PURE, detected from its recent SEC filings · based on capital-structure filings through 2026-06-15.
Going Concern Warning · Massive Potential Dilution
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →